• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白受体配体结合域的突变分析

Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.

作者信息

Esser V, Limbird L E, Brown M S, Goldstein J L, Russell D W

机构信息

Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

J Biol Chem. 1988 Sep 15;263(26):13282-90.

PMID:3417658
Abstract

The ligand binding domain of the low density lipoprotein (LDL) receptor contains seven imperfect repeats of a 40-amino acid cysteine-rich sequence. Each repeat contains clustered negative charges that have been postulated as ligand-binding sites. The adjacent region of the protein, the growth factor homology region, contains three cysteine-rich repeats (A-C) whose sequence differs from those in the ligand binding domain. To dissect the contribution of these different cysteine-rich repeats to ligand binding, we used oligonucleotide-directed mutagenesis to alter expressible cDNAs for the human LDL receptor which were then introduced into monkey COS cells by transfection. We measured the ability of the mutant receptors to bind LDL, which contains a single protein ligand for the receptor (apoB-100), and beta-migrating very low density lipoprotein (beta-VLDL), which contains apoB-100 plus multiple copies of another ligand (apoE). The results show that repeat 1 is not required for binding of either ligand. Repeats 2 plus 3 and repeats 6 plus 7 are required for maximal binding of LDL, but not beta-VLDL. Repeat 5 is required for binding of both ligands. Repeat A in the growth factor homology region is required for binding of LDL, but not beta-VLDL. Repeat B is not required for ligand binding. These results support a model for the LDL receptor in which various repeats play additive roles in ligand binding, each repeat making a separate contribution to the binding event.

摘要

低密度脂蛋白(LDL)受体的配体结合结构域包含一段40个氨基酸的富含半胱氨酸序列的七个不完全重复序列。每个重复序列都含有成簇的负电荷,这些负电荷被假定为配体结合位点。该蛋白的相邻区域,即生长因子同源区域,包含三个富含半胱氨酸的重复序列(A - C),其序列与配体结合结构域中的不同。为了剖析这些不同的富含半胱氨酸重复序列对配体结合的贡献,我们使用寡核苷酸定向诱变来改变人LDL受体的可表达cDNA,然后通过转染将其导入猴COS细胞。我们测量了突变受体结合LDL(其含有该受体的单一蛋白配体apoB - 100)和β迁移极低密度脂蛋白(β-VLDL,其含有apoB - 100加上另一种配体(apoE)的多个拷贝)的能力。结果表明,重复序列1对于两种配体的结合都不是必需的。重复序列2加3以及重复序列6加7对于LDL的最大结合是必需的,但对于β-VLDL则不是。重复序列5对于两种配体的结合都是必需的。生长因子同源区域中的重复序列A对于LDL的结合是必需的,但对于β-VLDL则不是。重复序列B对于配体结合不是必需的。这些结果支持了一种LDL受体模型,其中各种重复序列在配体结合中起累加作用,每个重复序列对结合事件都有单独的贡献。

相似文献

1
Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.低密度脂蛋白受体配体结合域的突变分析
J Biol Chem. 1988 Sep 15;263(26):13282-90.
2
Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins.
J Biol Chem. 1989 Dec 25;264(36):21682-8.
3
[Effects of induced deletion of repeats in binding domain of the VLDL receptor on its ligand-binding capacity].[诱导性删除极低密度脂蛋白受体结合结构域中的重复序列对其配体结合能力的影响]
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Mar;34(2):158-64.
4
Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.
J Biol Chem. 1986 Oct 5;261(28):13114-20.
5
A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands.低密度脂蛋白受体的一个双模块区域,足以与载脂蛋白E配体形成复合物。
Biochemistry. 2004 Feb 3;43(4):1037-44. doi: 10.1021/bi035529y.
6
Receptor-ligand interaction between vitellogenin receptor (VtgR) and vitellogenin (Vtg), implications on low density lipoprotein receptor and apolipoprotein B/E. The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg.卵黄蛋白原受体(VtgR)与卵黄蛋白原(Vtg)之间的受体-配体相互作用,对低密度脂蛋白受体和载脂蛋白B/E的影响。VtgR的前三个配体结合重复序列与Vtg的氨基末端区域相互作用。
J Biol Chem. 2003 Jan 31;278(5):2799-806. doi: 10.1074/jbc.M205067200. Epub 2002 Nov 11.
7
Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.低密度脂蛋白受体第一个富含半胱氨酸重复序列的缺失会损害其在家族性高胆固醇血症患者成纤维细胞中的转运,但不影响脂蛋白结合。
Proc Natl Acad Sci U S A. 1988 Nov;85(21):7912-6. doi: 10.1073/pnas.85.21.7912.
8
Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactions.人和猪载脂蛋白B的拟低密度脂蛋白(LDL)受体结合域的一级结构比较:对LDL受体相互作用的影响
J Lipid Res. 1988 Nov;29(11):1501-9.
9
Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation.从低密度脂蛋白受体中删除两个生长因子重复序列会加速其降解。
Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):677-82. doi: 10.1042/bj2770677.
10
Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.脂蛋白脂肪酶介导低密度脂蛋白受体增强极低密度脂蛋白结合及分解代谢的结构-功能关系。覆盖催化中心的正确折叠表面环的功能重要性。
J Biol Chem. 1996 Sep 6;271(36):21906-13. doi: 10.1074/jbc.271.36.21906.

引用本文的文献

1
Synergistic effects of mutation and glycosylation on disease progression.突变与糖基化对疾病进展的协同作用。
Front Mol Biosci. 2025 Feb 4;12:1550815. doi: 10.3389/fmolb.2025.1550815. eCollection 2025.
2
Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor.与低密度脂蛋白受体结合的载脂蛋白B100的结构
Nature. 2025 Feb;638(8051):829-835. doi: 10.1038/s41586-024-08223-0. Epub 2024 Dec 11.
3
Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization.
对高胆固醇血症患者中报告的低密度脂蛋白受体(LDLR)错义变体进行的细胞和功能评估表明,它们对转运和LDL内化具有低表达影响。
Front Cell Dev Biol. 2024 Jul 24;12:1412236. doi: 10.3389/fcell.2024.1412236. eCollection 2024.
4
LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.低密度脂蛋白受体(LDLR)基因c.89_92dup:家族性高胆固醇血症中的一种新型移码变异。
Lipids Health Dis. 2024 Jun 12;23(1):182. doi: 10.1186/s12944-024-02173-2.
5
Prevalent Variants in the LDLR Gene Impair Responsiveness to Rosuvastatin among Family Members of Patients with Premature Myocardial Infarction.低密度脂蛋白受体(LDLR)基因常见变异影响早发心肌梗死患者家庭成员对瑞舒伐他汀的反应性。
J Pers Med. 2023 Dec 18;13(12):1725. doi: 10.3390/jpm13121725.
6
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies.家族性高胆固醇血症中遗传变异的预测建模和结构分析:对诊断和蛋白质相互作用研究的影响。
Curr Atheroscler Rep. 2023 Nov;25(11):839-859. doi: 10.1007/s11883-023-01154-7. Epub 2023 Oct 17.
7
Proteolysis of the low-density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases.肝细胞中低密度脂蛋白受体的蛋白水解作用是由 BMP1 介导的,而不是由其他 astacin 蛋白酶介导的。
FEBS Lett. 2023 Jun;597(11):1489-1502. doi: 10.1002/1873-3468.14667. Epub 2023 Jun 5.
8
CysDB: a human cysteine database based on experimental quantitative chemoproteomics.CysDB:一个基于实验定量化学蛋白质组学的人类半胱氨酸数据库。
Cell Chem Biol. 2023 Jun 15;30(6):683-698.e3. doi: 10.1016/j.chembiol.2023.04.004. Epub 2023 Apr 28.
9
Vitellogenin receptor transports the 30K protein LP1 without cell-penetrating peptide, into the oocytes of the silkworm, .卵黄原蛋白受体将不含细胞穿透肽的30K蛋白LP1转运到家蚕的卵母细胞中。
Front Physiol. 2023 Jan 26;14:1117505. doi: 10.3389/fphys.2023.1117505. eCollection 2023.
10
Structures of LRP2 reveal a molecular machine for endocytosis.LRP2 结构揭示了胞吞作用的分子机器。
Cell. 2023 Feb 16;186(4):821-836.e13. doi: 10.1016/j.cell.2023.01.016. Epub 2023 Feb 6.